atai life sciences

Psychedelic Business Spotlight – December 17
December 17, 2021June 2, 2024 Business, Learn, Stock Reports

This week in psychedelic business news: Cybin steps closer to a new patent; MindMed appoints new CEO; MAPS and Wesana Health resume negotiations.
Psychedelic Business Spotlight: October 15
October 15, 2021June 2, 2024 Business, Learn, Stock Reports

This week in psychedelic business news: Cybin inhales; atai Life Sciences expands; DEA grants new psilocybin license; and FDA backs ketamine.

Psychedelic Business Spotlight – December 17